chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt said, next day after vaccine given, her left arm began to throb, and hurt. It became very red and hot, the swelling was enormous and very firm. She could not raise it but a few inches from her side. Today, 9/2/03, the redness is approx 6 x 6 in size. Some firmness still present. It's warm to touch and she can bring it up halfway her shoulder. She is afebrile today (her temperature at the time was 102).
p/vax pt passed out & fell fro chair to floor. pt was pale & diaphoretic w/dilated pupils. confused & slow to respond to questions. pt stated felt weak & dizzy & tired. pt appeared lethargic. at home pt remained dazed. 7/15 c/o dull HA
The injection was given high up on my arm and was very painful.  About an hour after receiving the shot my arm felt weak and my hand and fingers felt numb.  I could not raise my arm.  This lasted into the next day, when my shoulder began to hurt. The feeling returned to my hand but I started getting drawing pains in my arm, and increasing pain in my arm when raising it.
27 y/o female allergic reaction beginning with hives at the injection site (of covid vaccine) then becoming flushed in her face and neck. Denied swelling to her tongue. she has no facial edema. she denied difficulty breathing/SOB. She had equal and clear lung sounds bilateral. she denied feeling nauseous. she was not vomiting. she was given 50mg of diphenhydramine orally. vitals were taken and monitored. pt was transported to ED. PMH allergy to Bees 13:46 158/92 p91 r18 13:52 149/94 p91 r18
I have had a severe massive headache, nauseated, vomiting, sharp  pain on my left breast   and fever of 101 today and have taken 1000mg of Tylenol for the past three days now. I can?t keep anything down. I have sent a message via my chart and have yet to hear back. I feel absolutely horrible from this Pfizer vaccine.
First dose received on 1/20/2021.  Scheduled for 2nd dose on 02/19/2021.  Second dose appointment cancelled and reset for 03/01/2021.  Rescheduled second dose appointment cancelled again and reset for 03/05/2021.  This new appointment now exceeds the CDC guideline of 42 days.  Second dosed were administered to people who had received the first dose after me.  Concerned about effectiveness of second dose.
Information has been received from a physician concerning a patient who on an unspecified date was vaccinated with one dose of varicella virus vaccine live. (site unknown). One year post-vaccination, The patient developed breakthrough varicella with a small number of lesions. The patient recovered. Additional information has been requested.
Severe flu like symptoms within 30 minutes of 1st injection that lasted 9 days. Injection site swelled to size of softball. Day of first dose I walked up the stairs to my 3rd floor apartment and had to stop and began dry heaving. Experienced chest pains ranging from burning to sudden sharp punch. These pains continue to be experienced a year later. For months after first dose would experience sudden heart rate increase alongside uncountable hyperventilating. Usually this would only last for a few minutes, but would happen multiple times daily.  At the time of first dose I was running a 3 mile loop 3 times a week and couldn't after the flu symptoms stopped. The first two weeks after starting back to running I couldn't run more than 100 feet without having to stop. At second dose I experienced stroke symptoms. I woke up in the middle of the night with worst migraine I have ever experienced. I have been through EMT-B school and I legitimately believed I was having a stroke. I tried to grab my phone off my nightstand less than a foot from me and physically could NOT move. Every time I tried every muscle I tried to more felt like it was tearing in half and the joint breaking. I laid in my bed for several hours like this unable to call for help. Eventually it stopped and when it did it was sudden. I spent the next several days with body aches and a headache. To this day I have felt off from that experience I can't really describe it in any other detail than that. I still have chest pains that nobody can find a reason for.
Information has been received from a health professional concerning an 11 year old male who on 05-SEP-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) ("Lot # 05976"). On 05-SEP-2007, the patient developed a nickel size red mark at injection site, that was painful to touch. At the time of reporting the patient was not yet recovered. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Pt presented in our office today with a generalized maculo-papular rash all over body.
Fever of 100.7 and chills. Fever did break at 6am on 1/29/21 (next day after vaccination).
She had microscopic hematuria and iron deficiency anemia on labs drawn on the day of the vaccination. She is also treated with aspirin and Eliquis for an underlying heart conditions. The hematuria appeared to be consistent with a UTI. After treatment with two different antibiotics sequentially, the urine culture was negative. The gross hematuria persists.
Patient was given pediatric Pfizer (5-11 y/o) for first dose, though she was over 12 at the time. Vaccine administered at an event of primarily pediatric Pfizer. Per guidelines. the 2nd dose of the primary series will be adult/adolescent Pfizer.
Red, swollen area about 3 inch diameter at injection site as reported by patient. Very sore, swollen arm. Tender,  unable to lie down on left side. No systemic symptoms.
At clinic for first pfizer vaccine .  Lightheaded after vaccine Walked to observation area Given ice pack and water.  BP 110/60 seen by Dr. observed x 30 min D/c to home
I received the 1st Shingrix  injection  4/29/2019  in the right deltoid.  Side effects  noted with mild headache,mild body aches, and skin rash  in the area of the injection that resolved  without issue.  The second Shingrix injection as 7/9/2019 in the right deltoid  lower in the upper arm muscle.  No significant reaction but noted arm pain with  rash.  November Thanksgiving weekend noted in the right arm a hard, non tender mass below the epidermis  that was itchy, when rubbed a rash similar to the rash  with the previous injections. Treated with Benadryl  that resolved in week or 10 days. I also noted a mild headache and stiff neck at that time similar to the headache with the 1st shot but milder. I did not seek medical care as  the antihistamine treated the rash appearance, and the lump resolved.   Monday 1/13/2020 , I awoke with a hard mass  of considerable size in the same location  non tender. I only noticed when applying moisturizer. The area was  reactive to rubbing as it was itchy. There is no pain, and benadryl again seems to be resolving the rash and lump. I could not identify another etiology, ie bug bite ,injury . Again I did  not seek medical care as the area responds to the antihitamine   as it is resolving  the rash is almost gone and the lump is smaller
Patient received Moderna dose on 2/4/21, 18 days after Pfizer dose 1 on 1/17/21. Denies any issues with Pfizer vaccine. Feeling well after Moderna dose with no reported side effects.
brought to ED via EMS from SNF; pt is lethargic, no responding to questions; jerking all over (chills or rigors); O2 sats 85%; positive for COVID in ED; pt receiving O2 via NC; pt's condition deteriorated quickly and per death certificate, pt passed away in the ED
Patient was given his Pfizer booster a month earlier before it was needed. There was no reaction to the vaccine and patient was notified about the incident.
This spontaneous report as received from a nurse refers to multiple patients of unknown demographics. The reporter stated that the patients received improperly stored GARDASIL (lot number/expiry date unknown) on unknown dates (incorrect product storage). No adverse effects reported. The outcome was unknown. Excursion information for the vaccine: High temperature: 30 Minutes at 11.2 degree Celsius. Lowest temperature cumulative: 3 Hours and 17 Minutes at 0.4 degree Celsius. It was confirmed that the vaccines that were incorrectly stored were administered. There were no previous temperature excursions. Data logger was involved. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
On 2/4/21 I received the first shot, on 2/23/21 I experienced a severe nose bleed with approx. 300-500ml of blood loss. on 3/4/21, I received the second shot, on3/5/21 I experienced another severe nose bleed with approx. 50-100ml of blood loss.
PICKED UP FROM SCHOOL 11/19/2009 AT 1:30PM WITH VOMITING. VOMITED 6X. NO FEVER. SORE THROAT, H/A, TIRED, STOMACH ACHE. CALLED DR. OFFICE AND TOLD TO HOLD FLDS X2 HOURS AND THEN BEGIN SLOWLY. 11/20/09 AM NO VOMITING NOW, TAKING PO. 2 OTHER CHILDREN AT SCHOOL WITH GI SX UNRELATED TO VACCINE.
suspected vaccination failure; Neisseria meningitidis; congestion; Sinusitis; This serious case was reported in a literature article and described the occurrence of vaccination failure in a 19-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.  Co-suspect products included Men B NVS (Bexsero) for prophylaxis, Men ACWY-CRM NVS (Menveo) for prophylaxis and MENACTRA for prophylaxis.   The patient's past medical history included chronic allergic rhinosinusitis and functional endoscopic sinus surgery (FESS occurred 3.5 months prior to diagnostic visit).   On an unknown date, the patient received the 1st dose of Bexsero, the 2nd dose of Bexsero, Menveo and the 1st dose of MENACTRA. On an unknown date, an unknown time after receiving Bexsero, Bexsero and Menveo, the patient experienced vaccination failure (Verbatim: suspected vaccination failure) (serious criteria GSK medically significant), neisseria meningitides meningitis (Verbatim: Neisseria meningitidis) (serious criteria GSK medically significant), nasal congestion (Verbatim: congestion) and sinusitis (Verbatim: Sinusitis). The patient was treated with cefdinir. The outcome of the vaccination failure was unknown and the outcome of the neisseria meningitides meningitis, nasal congestion and sinusitis were resolved.   The reporter considered the vaccination failure, neisseria meningitides meningitis, nasal congestion and sinusitis to be related to Bexsero, Bexsero and Menveo. It was unknown if the reporter considered the vaccination failure, neisseria meningitides meningitis, nasal congestion and sinusitis to be related to Meningococcal B Vaccine Pre-Filled Syringe Device and Meningococcal B Vaccine Pre-Filled Syringe Device.   The company considered the vaccination failure, neisseria meningitides meningitis, nasal congestion and sinusitis to be related to Bexsero, Bexsero and Menveo. It was unknown if the company considered the vaccination failure, neisseria meningitides meningitis, nasal congestion and sinusitis to be related to Meningococcal B Vaccine Pre-Filled Syringe Device and Meningococcal B Vaccine Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 25-AUG-2023  This case corresponds to 19-year-old female patient mentioned in the literature article.  A patient with a history of chronic rhinosinusitis status after bilateral FESS 3 months prior presented with 1 week of congestion. Patient was an undergraduate collegiate student-athlete and member of the varsity track and field team. Sinonasal endoscopy and cultures returned positive for Neisseria meningitidis and patient was started on cefdinir with resolution of symptoms. Patient completed both the MenACWY and MenB series prior to the initial infection.  This case has been considered as suspected vaccination failure as the time to onset was unknown.
Immediate swelling, erythema, induration and extreme pain and paresthesia of the arm involving almost half her her arm. Medical record states dyspnea. msv
severe vertgo, with nausea after 12 hours from vaccine administration, continued vertigo with decrease in severity over a week.
Didn?t have any reactions til about 8 hours after shot. Arm is really sore up to my neck, chills and fatigue
FIrst week: Left arm where dosage was given: hard like a ball, tender, sore. Body Achy, extreme fatigue. At wake up eyes dry Second week: Left arm still hard like a knot, feverish, skin area red.  Facial cheeks red daily, Body aching, fatigued, Headache and in a daze - unclear foggy thinking.   Third week: Left arm itchy, knot gone, redness gone. Body aches less minimal, less sleepy. Headaches are stronger and I drink about 1/2 gallon of water per day. Facial cheeks red on and off.  Fogginess and dizziness still present.   Next injection 03/19/2021 - same location and time
Patient developed redness and pain at the injection site. Treatment given was instructions to the patient to use an ice pack, take ibuprofen, and BENADRYL.
chills, slight fever, headache, for 10-15 minutes. Symptoms came on suddenly and went away on their own. (Events were more "annoying" than "adverse.")
Shortly after vaccination felt dizzy and sweaty. After the feeling had passed patient felt 100 percent. 15 Mins later a second wave of dizziness happened, and the patient projectile vomited. Shortly after they vomited,  her blood pressure was checked and was really low as well as heart. The collar bone to the bottom lip was blue. After 40 mins her heart rate and blood pressure slowly went back to normal. Was advised to go to the hospital via ambulance. At the hospital patient was 100 percent feeling good, and dotocrs checked her blood pressure to see if it was stable. It was.
This spontaneous report as received from a registered nurse refers to a 68 year old female patient with no pertinent medical history and no drug reactions/allergies. The patient was intramuscularly vaccinated with the first and second dose of PNEUMOVAX23 int the left deltoid both 0.5 ml, respectively on 30-JUL-2009 and 22-APR-2013. The second dose lot number reported as H017759, expiry date 04-JUL-2014. The nurse was reporting that patient experienced a severe injection site reaction after administration of PNEUMOVAX23. The patient was administered PNEUMOVAX23 intramuscularly on the left deltoid on 22-APR-2013. The patient called the office 3 hours later complaining of redness and swelling below the injection site. The patient was advised to take ADVIL and alternate hot and cold compresses. On 23-APR-2013, the patient came to the office with severe tightness, tenderness, and warmth from the injection site extending past her left elbow. At the time of the report, no additional treatment had been prescribed. On 23-APR-2013 the patient's complete blood count was normal. The outcome of the patient's adverse events was reported as not recovered/not resolved. Additional information is not expected.
recently had a Shingrix vaccination on 1/15 and developed a painful, R-sided facial rash over the weekend. He initially saw ENT last Monday (1/18) for sinus pressure and was started on prednisone 20mg daily taper and a Zpack for presumed sinusitis. Given worsening congestion (no relief), his ENT switched the antibiotic to augmentin. At ENT follow up a few days later (1/26), patient developed the R-sided frontal rash and he was referred immediately to Ophtho who performed an eye exam and started valtrex for facial shingles. Patient has taken 2 doses of valtrex and is frustrated that his headache is not getting better and he still has tactile pain on the scalp. He has also noticed increased eyelid swelling the past 2 days since stopping his augmentin. ROS is negative for vision changes, pain with EOM, vertigo, otalgia, or increasing nausea. Associated symptoms include multiple cold sores and conjunctivitis. He was given erythromycin eye drops given concern for secondary bacterial infection.
Information has been received from a physician concerning a 16 year old female who was vaccinated with a first dose of Gardasil.  Concomitant therapy included MENACTRA.  Patient fainted 15 minutes after receiving her first dose of Gardasil.  Subsequently, the patient recovered.  Additional information has been requested.
Flushing/sweating, dizziness, generalized weakness, nausea. BP 94/51; HR 60; RR 19. 17 min post vaccination pt noted feeling much better. Denies pain/discomfort, no n/v. Fluid offered, seen by NP. Pt feeling better & released
Patient received the Moderna vaccine, her 2nd, on 5/4/2021 at about 10:30 am.  By 6 pm that evening, she started to experience some low back pain - was uncomfortable to sleep.  At 8:30 am on 5/5/2021, she woke at 0830 with a T 102.7.  She took 400 mg ibuprofen and went to bed.  Slept from 09:00 until 14:00.  Woke with a T 103.5.  State that she felt drowsy and was having body aches - particularly in her back.  On date of call, she was experiencing pain the length of her spine.
feels like Covid virus, after first vaccine; Feeling dizzy, after the first vaccine; Sore, clarified as in his diaphragm, after the first vaccine; Increased hunger, after first vaccine; This is a spontaneous report from a contactable consumer, the patient. A 59-years-old male patient received bnt162b2 (PFIZER-BIONTECH  COVID 19 VACCINE, Lot number :UNKNOWN), dose 1 via an unspecified route of administration, administered in Arm Left on 21Apr2021 04:00 as single dose for covid-19 immunisation. Medical history included open heart surgery from 2015 to 2015 (Verbatim: open heart surgery, he had a quintuple heart bypass) , ongoing high blood pressure (he could have had high blood pressure long before 2015), unknown , High cholesterol increased from 2015 and ongoing, acid reflux , heart condition. Concomitant medication(s) included metoprolol taken for heart condition, previous heart surgery from 2015 and ongoing at 50 mg by mouth once a day, lisinopril taken for heart condition and high blood pressure from 2015 and ongoing. 20 mg by mouth once a day, simvastatin taken for Blood cholesterol from 2015 and ongoing at 20 mg by mouth once a day, 40 mg by mouth once a day, pantoprazole taken it so he does not think he was having a heart attack, and for acid reflux from 2015 and ongoing at 20 mg by mouth once a day. The patient previously took flu shots (brand name and NDC, Lot and expiration date unknown, may be in his mid of 30's, it was 20 years ago) and he swelled up like a balloon. Patient had a normal aches and pains for a couple of days, on 29Apr2021, he started feeling the aches and pains again, and they went on until Friday. on 01May2021, he developed a sore throat and a nagging cough, which became dry and persistent. his breathing became labored, from midnight until 6 am, his breathing became so bad that he thought he was going to die. he had never experienced breathing problems like that, before. he was feeling dizzy on 03May2021. it felt like he had the Covid virus, with his breathing and all of these symptoms. he had not read anything about people having reactions, 8 days after the vaccine. he was not sure he wants to take the second vaccine, after going through all these events. he has gotten the flu and he had experienced an increase in hunger after the Covid vaccine. he didn't say for sure if all these events waere from the vaccine, after he went to bed last night, he hadn't eaten anything since that time, ate apples and vegetables. He goes to the doctor twice a year for heart tests and everything was normal. No history of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). Additional Vaccines was not Administered by patient on Same Date of the Pfizer Suspect. Patient did not took any drug within 4 weeks prior Vaccinations (within 4 weeks) Patient did not had any relevant tests. The Clinical outcome of the event for feels like Covid virus, after first vaccine was unknown and for other it was recovering.  Information on the lot/batch number has been requested.
Initial report received from a healthcare professional on 08 October 2013.  The patient had received FLUZONE 0.1 mg intradermal. No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: None.
Information has been received from a physician concerning a "late teens" female who completed the GARDASIL series, 0.5ml, IM in 2007. Recently (a couple of weeks ago) the patient had a routine screening and had tested positive for HPV. Therapy was reported as continued. The patient sought unspecified medical attention. At the time of the report the outcome of the patient was unknown. No further information is available.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021 at 1:29 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 07-Jan-2021 at 1:29 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 75.06 for dose administered on 07 Jan 2021.  No concomitant medications were reported.  Batch number 025L20A underwent temperature excursion on 07 Jan 2021.with temperature 34 degrees Fahrenheit at 09:00 AM to 10.00 AM. This vial was moved to fridge on 05 Jan 2021 and beyond use date for the vial was reported as 27 Jan 2021. Product moved to clinic on 07 Jan 2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.